Soaring rates of fatal fentanyl, methamphetamine, and cocaine overdoses have worsened and spread to previously insulated groups, including teenagers and the elderly

It has been more than a decade since the U.S. Centers for Disease Control and Prevention (CDC) declared a national opioid “epidemic,” also known as the opioid crisis. In that time, hundreds of thousands of people have died, with the impact rippling out amongst friends, family, and communities: One in three U.S. adults know someone who has died of an overdose.¹ 

Despite knowledge of this crisis and efforts to reduce fatal overdoses and impacts of substance use disorder, we have seen the opioid epidemic continually worsen and evolve. Evidence suggests that increased regulations on prescription opioids pushed many to illicit alternatives.² The COVID-19 pandemic coincided with a huge increase in overdose deaths. Fentanyl, a once lesser-known contributor to the epidemic, has skyrocketed in its impact. Once insulated groups, like adolescents and the elderly, have seen overdose rates rise.

In this new brief from SHADAC, we examine changes in drug overdose death rates, and the types of drugs that cause these fatal overdoses, during the pandemic period (2019-2022). We also look at the history of the opioid epidemic: its beginnings, factors that influenced its evolution, and what it looks like now.

With this brief focusing on the four most common causes of drug overdoses — fentanyl, prescription opioids, methamphetamine, and cocaine — just some of the findings from this pandemic period include:

• Fatal overdoses from fentanyl increased 99%
• Fatal overdoses from methamphetamine increased 108%, and 
• Fatal overdoses from cocaine increased 69%

While overdose death rates generally increased across all the measured racial and ethnic groups, “we […] found evidence of dramatic and growing disparities across racial and ethnic groups in rates of fatal overdoses, with the crisis increasingly harming American Indian and Alaska Native people and Black people during the pandemic era,” lead author and Senior Researcher Colin Planalp says. 

In this brief, we explore these findings and more, including looking deeper at the impacts of the opioid crisis on different communities, demographics, and states. Click here to read the brief in full. The appendix for this piece is available here.

[1] Kennedy-Hendricks, A., Ettman, C. K., Gollust, S. E., Bandara, S. N., Abdalla, S. M., Castrucci, B. C., & Galea, S. (2024). Experience of Personal Loss Due to Drug Overdose Among US Adults. JAMA health forum, 5(5), e241262. https://pubmed.ncbi.nlm.nih.gov/38819798/

[2] Pitt, A.L., Humphreys, K., & Brandeau, M.L. (2018). Modeling Health Benefits and Harms of Public Policy Responses to the US Opioid Epidemic. American Journal of Public Health, 108(10), 1394-1400. https://ajph.aphapublications.org/doi/pdfplus/10.2105/AJPH.2018.304590